Application segmentation of the Endoscopic Suturing Systems market isolates usage across clinical specialties. The gastrointestinal segment, encompassing procedures such as endoscopic submucosal dissection, full‑thickness resection, and bariatric revisions, accounts for roughly 55 % of total revenue, driven by the high incidence of colorectal and upper‑GI pathologies. The pulmonary segment, used for bronchoscopic closure of fistulas and post‑lung‑resection leaks, contributes about 20 % of the market, reflecting expanding minimally invasive thoracic interventions. The urological segment, applied in transurethral defect repair and vesicovaginal fistula closure, represents roughly 15 % of sales, supported by growing adoption of endoscopic techniques in urology. The residual other segment (approximately 10 %) aggregates niche uses such as otolaryngology and interventional radiology. Collectively, these application categories define the overall Endoscopic Suturing Systems segmentation, with each proportionate share influencing device design, pricing strategies, and geographic demand patterns.